Ponatinib 45mg Treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML)
Indications Ponatinib is a kinase inhibitor indicated for the: Treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Ph+ ALL for whom no other tyrosine kinase inhibitor (TKI) therapy is indicated. Treatment of adult patients with T315I-positive CML (chronic phase, accelerated phase, or blast phase) or T315I-positive […]